Transcript of "Effimune – product pipeline review – 2012"
Aarkstore.com announces, The Latest market research report is available inits vast collection:Effimune – Product Pipeline Review – 2012http://www.aarkstore.com/reports/Effimune-Product-Pipeline-Review-2012-217954.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “Effimune - Product Pipeline Review- 2012” provides data on the Effimune’s research and development focus. The reportincludes information on current developmental pipeline, complete with latestupdates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Effimune’s corporate website, SEC filings, investorpresentations and featured press releases, both from Effimune and industry-specificthird party sources, put together by Global Markets Direct’s team.Scope- Effimune - Brief Effimune overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Effimune human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 3List of Figures 3Effimune Snapshot 4Effimune Overview 4Key Information 4Key Facts 4Effimune – Research and Development Overview 5Key Therapeutic Areas 5Effimune – Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products – Monotherapy 8Effimune – Pipeline Products Glance 9Effimune – Early Stage Pipeline Products 9Pre-Clinical Products/Combination Treatment Modalities 9Discovery Products/Combination Treatment Modalities 10Effimune – Drug Profiles 11FR104 11Product Description 11Mechanism of Action 11R&D Progress 11MD707 12Product Description 12Mechanism of Action 12R&D Progress 12MF280 13Product Description 13Mechanism of Action 13R&D Progress 13MP196 14Product Description 14Mechanism of Action 14R&D Progress 14Effimune – Pipeline Analysis 15Effimune – Pipeline Products by Therapeutic Class 15Effimune – Pipeline Products By Target 16
Effimune – Pipeline Products By Mechanism of Action 17Effimune – Recent Pipeline Updates 18Effimune – Locations And Subsidiaries 19Head Office 19List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012BIOALVO S.A. – Product Pipeline Review – 2012Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cardio3 BioSciences SA – Product Pipeline Review – 2012Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012iCo Therapeutics Inc. – Product Pipeline Review – 2012Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
Mersana Therapeutics, Inc. – Product Pipeline Review – 2012Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012Nuon Therapeutics, Inc. – Product Pipeline Review – 2012Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012ProStrakan Group plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports firstname.lastname@example.orgFor More details Plz do contact :Aarkstore EnterpriseLavanya